title: [Femoral artery pseudo-aneurysms--changes in treatment, report of 7 years].
abstract: The femoral artery remains the most used peripheral site for radiological catheter access. With a greater number of both diagnostic and therapeutic procedures being performed by interventional radiologists and cardiologists, and with larger catheters being used for stenting and endovascular grafting, the incidence of iatrogenic pseudo-aneurysms reported has reached as high as 0.5-2%. Ideally, they should thrombus spontaneously. However, when this does not occur, management options include: observation, ultrasound-guided obliterative compression, direct thrombin injection, embolization, stent graft insertion, and very rarely-surgery. During a 7-year period (1992-1999) we treated 131 cases of femoral artery false aneurysms. Until 1998 ultrasound-guided compression-obliteration, with a 95% success rate, was our method of choice. Since 1998, direct thrombin injection, with 100% success in 24 cases, has become our preferred method. It is pain-free, fully successful even in anticoagulated patients, and is currently our treatment of choice.
authors.affiliation: Vascular Surgery Dept., Soroka Medical Center, Beer Sheba.
authors.forename: G
authors.initials: G
authors.lastname: Szendro
authors.forename: A
authors.initials: A
authors.lastname: Klimov
authors.forename: A
authors.initials: A
authors.lastname: Lennox
authors.forename: B
authors.initials: B
authors.lastname: Jonathan
authors.forename: L
authors.initials: L
authors.lastname: Avrahami
authors.forename: B
authors.initials: B
authors.lastname: Yechieli
authors.forename: M
authors.initials: M
authors.lastname: Griffin
authors.forename: S
authors.initials: S
authors.lastname: Yurfest
authors.forename: Y
authors.initials: Y
authors.lastname: Charach
authors.forename: L
authors.initials: L
authors.lastname: Golcman
authors.forename: A N
authors.initials: AN
authors.lastname: Nicolaides
mesh_terms: D017541:Aneurysm, False / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D000925:Anticoagulants / Q000627:therapeutic use; D005263:Femoral Artery; D006801:Humans; D012189:Retrospective Studies; D013917:Thrombin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D013917:Thrombin